This document discusses medication adherence and provides information on improving it. It defines medication adherence and discusses the burden of non-adherence, including economic costs and impacts on clinical outcomes. It describes factors that influence adherence, such as health system issues, patient factors, therapy complexity, and socioeconomic barriers. Effective interventions to improve adherence include simplifying regimens, educating patients, addressing beliefs, improving communication, evaluating adherence, and using team-based care approaches. Tools and resources are also provided.
medication Adherence defined as the act of filling a new prescription for the first time.
The extent to which the patients take medications as prescribed by the prescriber.
Patient medication adherence, Medication adherence, Causes of medication non-adherence, Problems linked with Medication Non-adherence, Factors affecting medication adherence, Patient related factors, Social and Economic factor, Disease related factor, Health care provider related factors, Therapy related factors, pharmacist role in the medication adherence, role of pharmacist in the medication adherence, monitoring of patient medication adherence, Direct method, Indirect method
what is patient counselling, objective of patient counselling, steps in patient counselling, patient counselling contents, process, conclusion, communicative skill for effective counselling, verbal communication, non verbal communications
Basic introduction to patient counselling for the clinical pharmacy services. Educating the patient on their disease, medication and lifestyle for better patient care and quicker recovery.
medication Adherence defined as the act of filling a new prescription for the first time.
The extent to which the patients take medications as prescribed by the prescriber.
Patient medication adherence, Medication adherence, Causes of medication non-adherence, Problems linked with Medication Non-adherence, Factors affecting medication adherence, Patient related factors, Social and Economic factor, Disease related factor, Health care provider related factors, Therapy related factors, pharmacist role in the medication adherence, role of pharmacist in the medication adherence, monitoring of patient medication adherence, Direct method, Indirect method
what is patient counselling, objective of patient counselling, steps in patient counselling, patient counselling contents, process, conclusion, communicative skill for effective counselling, verbal communication, non verbal communications
Basic introduction to patient counselling for the clinical pharmacy services. Educating the patient on their disease, medication and lifestyle for better patient care and quicker recovery.
Patient counseling is a process wherein pharmacist implements face-to-face interaction with the patient to provide information, orally or in written form, on directions of use & advice on side effects to help them to use their medications appropriately
Quality Use of Medicines means:
• Selecting management options wisely by:
Considering the place of medicines in treating illness and maintaining health, and
recognising that there may be better ways than medicine to manage many disorders.
• Choosing suitable medicines if a medicine is considered necessary so that the best available option is selected by taking into account:
- the individual
- the clinical condition
- risks and benefits
- dosage and length of treatment
- any co-existing conditions
- other therapies
- monitoring considerations
- costs for the individual, the community and the health system as a whole.
Patient Counselling is needed for
Better patient understanding to their illness and role of medication.
Improve medication adherence.
Improve dosage regimen adherence.
More effective Drug treatment.
Reduce incidence of adverse drug effect and unnecessary healthcare cost.
ADR reporting.
Improve quality of life for patient.
Raising image of Pharmacist & its profession.
Medication Adherence , setting up directions .. Ahmed Nouri
presenting the terminology of adherence, statistics of non-adherence and its impact, why do patients have difficulty with treatment, how to measure and how to improve the adherence, in addition to the role of the pharmacist in improving adherence.
DEFINITION
BACKGROUND
METHODS OF ASSESSING COMPLIANCE.
Factors concerned with compliance.
BARRIERS TO COMPLIANCE
IMPROVEMENT OF COMPLIANCE .
NON-COMPLIANCE FACTORS.
It is a very important topic in healthcare. Pharmacists must be aware of few important counselling points for every medicine. Community Pharmacist must be aware of counselling.
Patient counseling is a process wherein pharmacist implements face-to-face interaction with the patient to provide information, orally or in written form, on directions of use & advice on side effects to help them to use their medications appropriately
Quality Use of Medicines means:
• Selecting management options wisely by:
Considering the place of medicines in treating illness and maintaining health, and
recognising that there may be better ways than medicine to manage many disorders.
• Choosing suitable medicines if a medicine is considered necessary so that the best available option is selected by taking into account:
- the individual
- the clinical condition
- risks and benefits
- dosage and length of treatment
- any co-existing conditions
- other therapies
- monitoring considerations
- costs for the individual, the community and the health system as a whole.
Patient Counselling is needed for
Better patient understanding to their illness and role of medication.
Improve medication adherence.
Improve dosage regimen adherence.
More effective Drug treatment.
Reduce incidence of adverse drug effect and unnecessary healthcare cost.
ADR reporting.
Improve quality of life for patient.
Raising image of Pharmacist & its profession.
Medication Adherence , setting up directions .. Ahmed Nouri
presenting the terminology of adherence, statistics of non-adherence and its impact, why do patients have difficulty with treatment, how to measure and how to improve the adherence, in addition to the role of the pharmacist in improving adherence.
DEFINITION
BACKGROUND
METHODS OF ASSESSING COMPLIANCE.
Factors concerned with compliance.
BARRIERS TO COMPLIANCE
IMPROVEMENT OF COMPLIANCE .
NON-COMPLIANCE FACTORS.
It is a very important topic in healthcare. Pharmacists must be aware of few important counselling points for every medicine. Community Pharmacist must be aware of counselling.
Within integrative medicine “adherence” is more than ensuring patients remembering to take their medication. It's about adhering to a new lifestyle, exercise routine, ditching bad habits, incorporating a new nutrition plan (in addition to medication or supplement use). This slide show take a look at the differences between "patient adherence" and "patient compliance", areas of adherence, the consequences of non-adherence and what you can do as their healthcare professional.
Global Trends in e-Health and Medication Adherence by Yuri Quintana, Ph.D. 1...Harvard Medical School
This presentation provides an overview of global health trends and medication adherence challenges. A review of some mobile medication adherence solutions is given. A discussion is provided on some early observations from usability studies. Future design considerations for medication adherence systems are discussed.
Describes in detail the concept of compliance to therapeutic regimen, difference between adherence and compliance, factors which influence compliance, methods of assessing, reasons for non-compliance and strategies to improve compliance to the therapy.
Team Lift: Predicting Medication AdherenceNeil Ryan
Medication adherence is a growing public health concern in the US. It is the extent to which patients are taking medications as prescribed by their healthcare providers. Simply put, are patients eating their pills on time?
We looked at patient data from Medicare part D program released by Centers for Medicare & Medicaid services. We built a prediction model to ascertain whether a patient would be adherent based on a variety of social, economic and behavioral aspects.
SELF MEDICATION PRACTICES FOR ORAL HEALTH PROBLEMS AMONG DENTAL PATIENTS IN B...iosrphr_editor
Introduction: Self‑ medication is commonly practiced all over the world. Self-medication is defined as the use
of medication by a patient on his own initiative or on the advice of a pharmacist or a lay person instead of
consulting a medical practitioner. The present study was aimed to estimate the prevalence of self-medication for
oral health problems among dental patients in Bengaluru city; to identify triggering factors that could influence
self-medication practices; to identify sources of medications used; to identify sources of information about
medications used; and to identify reasons for self-medication.Study Design: A Cross sectional Study.Methods:A
survey was conducted among 175 subjects among dental patients in Bengaluru city. Data were collected
through a specially designed proforma using a closed‑ ended, self‑ administered questionnaire containing 15
questions, in five sections.
Results: The prevalence of
Provider Based Patient Engagement - An Essential Strategy for Population HealthPhytel
As the healthcare industry starts to re-engineer care delivery to accommodate new reimbursement models, providers on the front lines of change recognize the need for population health management and for increasing patients’ engagement in their own care. These two approaches are inextricably bound together, because it is impossible to manage the health of a population without getting patients more involved in self-management and the modification of their own risk factors. This paper discusses the fundamentals of patient engagement and shows how automation tools and web-based care management can facilitate this key process.
BRP Pharmaceuticals is a leader in physician dispensing services that provides instant medication to patients located in Burbank, CA. Visit: http://www.brppharma.com/
Knowledge, Attitude and Practice of Self-Medication among Medical Studentsiosrjce
Self-medication is a common practice worldwide and the irrational use of the drugs is a major
cause of concern. Self-medication is an issue with serious global implication. The current study aimed to
determine the Knowledge, Attitude and Behavior of self-medication by medical students. A descriptive crosssectional
study was conducted among medical students currently studying first year to assess knowledge,
attitude and practice regarding self-medication in Chitwan Medical College, Bharatpur, Nepal. Seventy five
students studying in first year were selected for the study using stratified random sampling technique and data
was collected using a semi-structured self-administered questionnaire. The study finding revealed, the mean age
of 75 enrolled students was 20 years, 65.3% were in the age group of 17-20 years. Most of them were female
(72%). Seventy three point three percent belong to urban area. Prevalence rate of self-medication of one year
period seems high i.e. 84% and 68.25% in were females. The most common sources of information used by the
respondent were pharmacist (60.31%) and text book (46.03%). More than half of the respondent found to have
a good knowledge about self-medication regarding definition, adverse effect and different types of drug. The
attitude was positive towards self-medication and favored self-medication saying that it was acceptable. The
principal morbidities for seeking self-medication include cold and cough as reported by 85.7% followed by pain
76.2%, fever 73%, diarrhea 47.6% and dysmenorrheal 46%. Drugs / drugs group commonly used for selfmedication
included analgesics 75.8%, and anta-acids 53.2% and antipyretic 46.3%. Among reasons for
seeking self-medication, 79.2% felt that their illness was minor while 61.9% preferred as it is due to previous
experience. This study shows that self-medication is widely practiced among first year students of this medical
institution. There is dire need to make them aware about the pros and cons of self-medication in order to ensure
safe usage of drugs.
Prof. Judith H. Hibbard: The King's Fund Annual ConferenceThe King's Fund
Professor Judith H. Hibbard, Professor of Health Policy, University of Oregon talks about increasing patient activation to improve outcomes and reduce costs at The King's Fund Annual Conference.
Introduction: Medication adherence is defined by the World Health Organisation as “The degree to which the person's behaviour corresponds with the agreed recommendations from a health care provider
Factor Affecting Non-Adherance:Poor adherence or non-adherence to medical treatment severely compromises patient outcomes and increases patient mortality.
Non-adherence is a very common phenomenon in all patients with drug-taking behaviour.
The complexity of adherence is the result of an interplay of a range of factors, including patient views and attributes, illness characteristics, social contexts, access, and service issues.
Non-adherence: Non-adherence is the failure or refusal to comply with advice and can imply disobedience on the part of patient
5 step Factors: Social/economic and Economic Factors
Provider-patient/health care system factors
Condition-related factors
Therapy-related factors
Patient-related factors
Behavioural Factors:
Life style (smoking, alcohol, coffee use) Psychological and personality factors: anxiety, depression, coping style
Biological factors:
Gender, age, and genetic predisposition
Social and cultural factors:
Educational level, living situation, price of medication, policies.
Information Factors:
Have you received enough information? Satisfaction with the last visit?
Awareness factors:
Severity of the complaints (Baseline) quality of life,
Locus of control about patient adherence:
internal and external, stability and control about the cause of the complaints: internal and external, stability and controllability.
Stages to Overcome This Barrier
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
Medication adherence-01ccd 2
1. Medication Adherence
[Primary care educators may use the following slides for
their own teaching purposes]
CDC’s Noon Conference
March 27, 2013
2. Overview of This Educational Module
Medication adherence
Burden of non-adherence
Effective interventions to improve adherence
Measuring medication adherence
Provider’s role in improving medication adherence
Tools and resources
Case studies
4. What is Adherence?
Cluster of behaviors
Simultaneously affected by multiple factors
The extent to which a person’ s behavior—taking
medication, following a diet, or making healthy lifestyle
changes—corresponds with agreed-upon
recommendations from a health-care provider
World Health Organization, 2003
Source: http://apps.who.int/iris/bitstream/10665/42682/1/9241545992.pdf
5. What is Medication Adherence?
Medication Adherence: The patient’s conformance with the
provider’s recommendation with respect to timing, dosage,
and frequency of medication-taking during the prescribed
length of time
Compliance: Patient’s passive following of provider’s orders
Persistence: Duration of time patient takes
medication, from initiation to discontinuation
of therapy
Source:
http://www.effectivehealthcare.ahrq.gov/ehc/products/296/1248/EvidenceReport208_CQGMedAdherence_FinalReport_
20120905.pdf
7. Objectives of This Module
Learn ways to improve medication adherence rates
Develop a summary of existing evidence-based
knowledge
Inform, raise awareness, and promote discussion
among patients, clinicians, pharmacists, payers, public
health practitioners, and decision makers about ways
to improve medication adherence
9. Background
Medication prescriptions never filled: 20% to 30%
Medication not continued as prescribed in about 50% of
cases
The World Health Organization estimated that by 2020,
the number of Americans affected by at least one chronic
condition requiring medication therapy will grow to 157
million
Sources: http://scriptyourfuture.org/wp-content/themes/cons/m/release.pdf ; Osterberg 2005, NEJM; Ho 2009, Circulation
10. Medication Adherence in United States
Rates of medication adherence drop after first six
months
Only 51% of Americans treated for hypertension are
adherent to their long-term therapy
About 25% to 50% of patients discontinue statins within
one year of treatment initiation
Source: Choudhry 2011, N Engl J Med; Yeaw 2009, J Manag Care Pharm; Script Your Future press release, November 2, 2011;
accessed here: http://scriptyourfuture.org/wp-content/themes/cons/m/release.pdf.
12. Non-Adherence—Economic
Direct cost estimated at $100 billion to $289 billion
annually
Costs $2000 per patient in physician visits annually
Improved self-management of chronic diseases results
in an approximate cost-to-savings ratio of 1:10
Cost-related non-adherence reported by 11.4%
(~543,000 individuals) of stroke survivors, mostly
among the uninsured and younger (45 to 64 years)
Sources: Ho 2009, Circulation; Levine et al. 2013, Annals of Neurology
13. Non-Adherence—Clinical Outcomes
High adherence to antihypertensive medication is
associated with higher odds of blood pressure control
Each incremental 25% increase in proportion of days
covered (PDC ) for statins is associated with ~3.8 mg/dl
reduction in LDL cholesterol
Source: Ho 2009, Circulation
14. Non-adherence—Mortality, Hospitalizations,
ED Visits
Non-adherence causes ~30% to 50% of treatment failures and
125,000 deaths annually
Non-adherence to statins increased relative risk for mortality
(~12% to 25%)
Non-adherence to cardioprotective medications increased
risk of cardiovascular hospitalizations (10% to 40%) and
mortality (50% to 80%)
Poor adherence to heart failure medications increased the
number of cardiovascular-related emergency department
(ED) visits
Sources: Ho 2009, Circulation; Edmondson 2013, Br J of Health Psychology; George & Shalansky 2006, Br J Clin Phar
16. Five Interacting Dimensions of
Non-Adherence
Health-care
system/team
factors
Source: http://apps.who.int/iris/bitstream/10665/42682/1/9241545992.pdf
Patient-related
factors
Therapy-related
factors
Condition-related
factors
Social and
economic
factors
17. Health-care Factors
Health-care Team
Stress of health-care visits
Discomfort in asking providers
questions
Patient’s belief or
understanding
Patient’s forgetfulness or
carelessness
Stressful life events
Lack of immediate benefit of
therapy
Health-care System
Access to care
Continuity of
care
Patient education
material not
written in plain
language
Sources: http://apps.who.int/iris/bitstream/10665/42682/1/9241545992.pdf
18. Provider Factors
Communication skills
Knowledge of health literacy issues
Lack of empathy
Lack of positive reinforcement
Number of comorbid conditions
Number of medications needed per day
Types or components of medication
Amount of prescribed medications or
duration of prescription
Source: Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane
Database Syst Rev 2008;(2):CD000011
19. Patient, Condition, and Therapy Factors
Condition- and therapy-related
Complexity of medication
Frequent changes in regimen
Treatment requiring mastery of
certain techniques
Unpleasant side effects
Duration of therapy
Lack of immediate benefit of therapy
Medications with social stigma
Patient-related
Physical
Psychological
Sources: http://apps.who.int/iris/bitstream/10665/42682/1/9241545992.pdf
20. Economic and Social Factors
Social
Limited English proficiency
Inability to access or difficulty
accessing pharmacy
Lack of family or social support
Unstable living conditions
Economic
Health insurance
Medication cost
Source: http://apps.who.int/iris/bitstream/10665/42682/1/9241545992.pdf
21. What May Providers Do to Overcome These
Challenges?
Communication is key!
Effective interventions
Measure medication adherence
Sources: Ratanawongsa 2012 Arch Intern Med ; Bramley 2006 J Manag Care Pharm 12(3):239-245; Martin 2011 Am J Health
Promot 25(6):372-378
23. SIMPLE
S— Simplify the regimen
I — Impart knowledge
M—Modify patient beliefs and behavior
P —Provide communication and trust
L —Leave the bias
E —Evaluate adherence
Source: http://www.acpm.org/?MedAdherTT_ClinRef
24. S—Simplify the Regimen
Adjust timing, frequency, amount, and dosage
Match regimen to patient’s activities of daily living
Recommend taking all medications at the same time of
day
Avoid prescribing medications with special requirements
Investigate customized packaging for patients
Encourage use of adherence aids
Consider changing the situation vs. changing the patient
Source: http://www.acpm.org/?MedAdherTT_ClinRef
25. I—Impart Knowledge
Focus on patient-provider shared decision making
Keep the team informed (physicians, nurses, and
pharmacists)
Involve patient’s family or caregiver if appropriate
Advise on how to cope with medication costs
Provide all prescription instructions clearly in writing
and verbally
Suggest additional information from Internet if patients
are interested
Reinforce all discussions often, especially
for low-literacy patients
Source: http://www.acpm.org/?MedAdherTT_ClinRef
26. M—Modify Patient Beliefs and Behavior
Empower patients to self-manage their condition
Ensure that patients understand their risks if they don’t
take their medications
Ask patients about the consequences of not taking their
medications
Have patients restate the positive benefits of taking their
medications
Address fears and concerns
Provide rewards for adherence
Source: http://www.acpm.org/?MedAdherTT_ClinRef
27. P—Provide Communication and Trust
Improve interviewing skills
Practice active listening
Provide emotional support
Use plain language
Elicit patient’s input in treatment decisions
Source: http://www.acpm.org/?MedAdherTT_ClinRef
28. L—Leave the Bias
Understand health literacy and how it affects outcomes
Examine self-efficacy regarding care of racial, ethnic, and
social minority populations
Develop patient-centered communication style
Acknowledge biases in medical decision making
Address dissonance of patient-provider, race-ethnicity, and
language
Sources: http://www.acpm.org/?MedAdherTT_ClinRef; Bandura, A. (1997). Self-efficacy: The exercise of control. New York: W.H.
Freeman; Bandura, A. (1994). Self-efficacy. In V.S. Ramachaudran (Ed.), Encyclopedia of human behavior;4. New York: Academic
Press, pp. 71-81.
29. E—Evaluating Adherence
Self-report
Ask about adherence behavior at every visit
Periodically review patient’s medication containers,
noting renewal dates
Use biochemical tests—measure serum or urine
medication levels as needed
Use medication adherence scales—for example:
Morisky-8 (MMAS-8)
Morisky-4 (MMAS-4, also known as the Medication Adherence
Questionnaire or MAQ)
Medication Possession Ratio (MPR)
Proportion of Days Covered (PDC)
Sources: http://www.acpm.org/?MedAdherTT_ClinRef; Morisky, DE & DiMatteo, MR. Journal of Clinical Epidemiology 2011; 64:262-
263; https://www.urac.org/MedicationAdherence/includes/Nau_Presentation.pdf
31. General Guide to Choosing Medication Adherence
Scales Based on Disease of Interest
Therapeutic Area Medication Adherence Scales
Metabolic Disorders:
hypertension, dyslipidemia, diabetes
MAQ (shortest to administer)
SEAMS (assesses self-efficacy)
BMQ (diabetes only)
Hill-Bone Compliance Scale
(hypertension in predominantly
black populations)
Mental Health:
schizophrenia, psychosis, depression
MARS (schizophrenia and psychosis)
BMQ (depression)
Abbreviations used:
BMQ = Brief Medication Questionnaire
MAQ = Medication Adherence Questionnaire (also known as the Morisky-4 or MMAS-4 scale)
MARS = Medication Adherence Rating Scale
SEAMS = Self-Efficacy for Appropriate Medication Use Scale
Source: Lavsa SM et al. J Am Pharm Assoc. 2011;51(1):90-94;
32. Interventions Should be Patient-Tailored
Behavior-related
Forgetfulness of patients
• Daily alerts
• 90 days medication supplies
• Automatic renewals
Clinical—Questions or concerns about medication
Pharmacist consultation
Linguistically and culturally appropriate
Cost-related
Payment assistance programs
Lower cost medication alternatives
Lower cost pharmacy option (e.g. , home delivery)
34. Effective Strategies for Improving Hypertension
Medication Adherence
Team-based care
Pharmacist-led multicomponent interventions
Education with behavioral support
Pill counting
Blister packaging
Electronic monitoring
Telecommunication systems for monitoring and counseling
Single dose vs. multiple dose prescribed
Sources: Walsh J, McDonald K, Shojania K, et al. Quality improvement strategies for hypertension management: a systematic
review. Medical Care 2006;44:646-57; Viswanathan M, Golin CE, Jones CD, Ashok M, Blalock SJ, Wines RC, et al. Interventions to
improve adherence to self-administered medications for chronic diseases in the United States: a systematic review. Ann Intern
Med 2012; 157(11):785-795.
35. How to Overcome Challenges or
Barriers by System Change
Introduce team-based care
Collaborate with pharmacists and/or nurses
Educate patients on how to take medications
Monitor by pill box
Improve access and communication
Offer patients the opportunity to contact the provider’s office with any
questions
Use telemedicine, particularly in rural areas
Use technologies and analytical services that facilitate measuring
and improved adherence
36. Script Your Future
National multiyear campaign to raise awareness about
medication adherence
This campaign brings together stakeholders in health
care, business, and government in six regional target
markets
For health-care professionals, the campaign offers
guidance on how to improve communication with
patients
For patients, the campaign offers practical tools to
improve medication adherence
Sources: http://scriptyourfuture.org/wp-content/themes/cons/m/release.pdf
37. US Surgeon General Regina Benjamin, MD
“Doctors, nurses, pharmacists and other health care
professionals can help prevent many serious health
complications by initiating conversations with their patients
about the importance of taking medication as directed. This is
especially important for people with chronic health
conditions such as diabetes, asthma and high blood pressure,
who may have a number of medicines to take each day.”
Source: http://scriptyourfuture.org/wp-content/themes/cons/m/release.pdf
38. Take-Home Messages for Providers
Display patience and empathy when interacting with
patients
Be mindful of the number of medications prescribed and
their frequency and dosages
Prescribe lower-cost medications and/or provide
manufacturer coupons to help lower costs
Explain the consequences of non-adherence and suggest
ways to improve adherence
Introduce team-based care to improve medication
adherence
Identify roles and responsibilities in team-based care to
deliver improved patient-centered health care
39. Tools
American Heart Association
Medicine Management Tool
American College of Cardiology
CardioSmart Med Reminder (mobile app)
National Heart, Lung, and Blood Institute, National
Institutes of Health
Tips to Help You Remember to Take Your Blood Pressure Drugs
American Society of Consultant Pharmacists Foundation
Adult Meducation: Improving Medication Adherence in Older Adults
Script Your Future
Wallet card for patients
Tools for providers
Sources: URLs added to notes section of this slide
40. CDC Resources
Educational Materials for Professionals. Division for
Heart Disease and Stroke Prevention.
Fact Sheets, Data and Statistics, Maps, Reports, Guidelines and
Recommendations. Available at
http://www.cdc.gov/dhdsp/materials_for_professionals.htm
Million Hearts: Prevention at Work.
Achieve excellence in the "ABCS" (A=Aspirin for people at risk,
B=Blood pressure control, C=Cholesterol management, S=Smoking
cessation). Available at
• http://www.cdc.gov/24-7/prevention/MillionHearts/
• http://millionhearts.hhs.gov/index.html
41. CDC Resources—(cont.)
Team Up. Pressure Down.
Providers may inform patients with high blood pressure to team up
with their pharmacist to better understand their condition and any
medications they are taking. Available at
http://www.cdc.gov/features/tupd/
http://millionhearts.hhs.gov/resources/teamuppressuredown.html#
Partners
A Program Guide for Public Health Partnering with
Pharmacists in the Prevention and Control of Chronic
Diseases. Division for Heart Disease and Stroke
Prevention and Division of Diabetes Translation.
This guide focuses on medication therapy management services
provided by pharmacists to improve medication adherence. Available
at
http://www.cdc.gov/dhdsp/programs/nhdsp_program/docs/Pharma
cist_Guide.pdf
42. Health Literacy Resources
American Medical Association Health Literacy Video
http://www.ama-assn.org/ama/pub/about-ama/ama-foundation/
our-programs/public-health/health-literacy-program/
health-literacy-video.page
http://www.youtube.com/watch?v=cGtTZ_vxjyA
AHRQ’s Health Literacy Universal Precautions Toolkit
http://www.innovations.ahrq.gov/content.aspx?id=2684
http://www.rihlp.org/pubs/Complete_toolkit_224pgs.pdf
American College of Physician Foundation Health
Literacy Programs and Resources on Medication
Labeling
http://www.acpfoundation.org/health-literacy-programs/
medication-labeling-2/
43. References
1. Casula M, Tragni E, Catapano AL. Adherence to lipid-lowering treatment: the patient
perspective. Patient Prefer Adherence 2012; 6:805-814.
2. Choudhry NK, Avorn J, Glynn RJ, Antman EM, Schneeweiss S, Toscano M, et al. Full
coverage for preventive medications after myocardial infarction. N Engl J Med
2011;365(22), 2088-2097.
3. Edmondson D, Horowitz CR, Goldfinger JZ, Fei K, Kronish IM. Concerns about
medications mediate the association of posttraumatic stress disorder with
adherence to medication in stroke survivors. Br J Health Psychol 2013 Jan 7; doi:
10.1111/bjhp.12022. [Epub ahead of print].
4. Elliott RA, Barber N, Horne R. Cost-effectiveness of adherence-enhancing
interventions: a quality assessment of the evidence. Ann Pharmacother 2005;
39(3):508-515.
5. Fongwa MN, Evangelista LS, Hays RD, Martins DS, Elashoff D, Cowan MJ, et al.
Adherence treatment factors in hypertensive African American women. Vasc Health
Risk Manag 2008; 4(1):157-166.
6. Fretheim A, Aaserud M, Oxman AD. Rational prescribing in primary care (RaPP):
economic evaluation of an intervention to improve professional practice. PLoS Med
2006; 3(6):e216.
7. George J, Shalansky SJ. Predictors of refill non-adherence in patients with heart
failure. Br J Clin Pharmacol 2007; 63(4):488-493.
44. References (cont.)
8. Gu Q, Burt VL, Dillon CF, Yoon S. Trends in antihypertensive medication use and blood
pressure control among United States adults with hypertension: the National Health
and Nutrition Examination Survey, 2001 to 2010. Circulation 2012; 126(17):2105-
2114.
9. Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: its importance in
cardiovascular outcomes. Circulation 2009; 119(23):3028-3035.
10. Ito K, Shrank WH, Avorn J, Patrick AR, Brennan TA, Antman, EM et al. Comparative cost-effectiveness
of interventions to improve medication adherence after myocardial
infarction. Health Serv Res 2012; 47(6):2097-2117.
11. Kronish IM, Edmondson D, Goldfinger JZ, Fei K, Horowitz CR. Posttraumatic stress
disorder and adherence to medications in survivors of strokes and transient ischemic
attacks. Stroke 2012; 43(8):2192-2197.
12. Levine DA, Morgenstern LB, Langa KM, Piette JD, Rogers MA, Karve SJ. Recent trends in
cost‐related medication nonadherence among US stroke survivors. Annals of Neurology
2013 Feb 22; doi: 10.1002/ana.23823. [Epub ahead of print].
13. Lyles CR, Karter AJ, Young BA, Spigner C, Grembowski D, Schillinger D, et al. Patient-reported
racial/ethnic healthcare provider discrimination and medication
intensification in the Diabetes Study of Northern California (DISTANCE). J Gen Intern
Med 2011; 26(10):1138-1144.
14. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication
adherence measure in an outpatient setting. J Clin Hypertens (Greenwich) 2008;
10(5):348-354.
45. References (cont.)
15. Morisky DE, DiMatteo MR. Improving the measurement of self-reported medication
nonadherence: response to authors. J Clin Epidemiol 2011; 64(3):255-257.
16. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005; 353(5):487-497.
17. Rasmussen JN, Chong A, Alter DA. Relationship between adherence to evidence-based
pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA
2007;297:177–186.
18. Ratanawongsa N, Karter AJ, Parker MM, Lyles CR, Heisler M, Moffet HH, et al.
Communication and medication refill adherence: the Diabetes Study of Northern
California. Arch Intern Med 2012 Dec 31;1-9.
19. Steiner JF, Ho PM, Beaty BL, Dickinson LM, Hanratty R, Zeng C, et al. Sociodemographic
and clinical characteristics are not clinically useful predictors of refill adherence in
patients with hypertension. Circ Cardiovasc Qual Outcomes 2009; 2(5):451-457.
20. Viswanathan M, Golin CE, Jones CD, Ashok M, Blalock SJ, Wines RC, et al. Interventions
to improve adherence to self-administered medications for chronic diseases in the
United States: a systematic review. Ann Intern Med 2012; 157(11):785-795.
21. Walsh J, McDonald K, Shojania K, et al. Quality improvement strategies for
hypertension management: a systematic review. Medical Care 2006;44:646-57.
22. Yeaw J, Benner JS, Walt JG, Sian S, Smith DB. Comparing adherence and persistence
across 6 chronic medication classes. J Manag Care Pharm 2009; 15(9), 728-740.
46. Acknowledgements
Farah M. Chowdhury, MBBS, MPH
Deesha Patel, MPH
Mary G. George, MD, MSPH, FACS
David Callahan, MD, FAAFP
For more information please contact Centers for Disease Control and Prevention
1600 Clifton Road NE, Atlanta, GA 30333
Telephone, 1-800-CDC-INFO (232-4636)/TTY: 1-888-232-6348
E-mail: cdcinfo@cdc.gov Web: www.cdc.gov
The findings and conclusions in this report are those of the authors and do not necessarily represent the official
position of the Centers for Disease Control and Prevention.
Division for Heart Disease and Stroke Prevention (DHDSP)
National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP)
Editor's Notes
Health-care system and team dimensions for medication non-adherence have multiple domains. Some related to health-care delivery are
Access to care—If patients are uninsured or underinsured, and thus have no access or poor access to care, they may not have the opportunity to treat their conditions and continue medication adherence.
Continuity of care—Continuity of care is important for controlling chronic conditions and continuation of long-term therapy.
Patient education materials may not be written in plain language. Consequently, patients may not be able to adequately understand instructions for their medication regimen.
In general, the health-care team is made up of both providers and patients. Some factors for medication non-adherence are related to the health-care team; these are factors related to both patient and providers or providers or patients only. For example:
Patients may consider health-care visits stressful.
Patients may feel discomfort in posing questions to providers.
Patients’ beliefs or understanding of the disease may differ from their providers’.
Patients may be forgetful or careless.
Stressful life events—for providers or patients—may play a role.
A lack of immediate benefit of therapy, resulting in an uncontrolled condition, may also play a role. For example, uncontrolled blood pressure at a follow-up visit is a potential risk factor for medication non-adherence.
Many provider-related factors affect medication non-adherence:
Provider communication skills
Lack of provider’s knowledge about health literacy and plain language. We included resources related to health literacy in the resource list; the American Medical Association offers a short video on this topic.
Lack of empathy. Researchers reported that providers miss 70% to 90% of opportunities to express empathy. Researchers defined empathic opportunities as instances where patients expressed a strong negative emotion, and they developed thematic categories to describe provider response by analyzing 47 visits between patients and their providers. Researchers categorized provider’s responses into “Ignore/Change Topic,” “Dismiss,” “Elicit,” “Problem Solving,” and “Empathic Response.” [Hsu et al. Patient Educ Couns. 2012;88(3):436-442.]
Lack of positive reinforcement from provider
Number of comorbid conditions
Number of medications needed per day
Types or components of medication
Amount of prescribed medications or duration of the prescription
Patient-related factors could be physical as well as psychological or behavioral. Some patient-related physical factors are
Visual, hearing, or cognitive impairments
Swallowing problems
Lack of or severity of symptoms
Chronic conditions (e.g., hypertension, diabetes mellitus)
Patient-related psychological factors include
Depression
Confidence in ability to follow treatment regimen
Fear of possible adverse effects or dependence
Expectations or attitude toward prescription
Some examples of condition- and therapy-related factors are
Complexity of medication regimen (for example, number of daily doses or number of concurrent medications)
Frequent changes in regimen
Treatment requiring mastery of certain techniques (for example, injections or inhalers)
Unpleasant side effects which may be actual or perceived
Duration of therapy
Lack of immediate benefit of therapy
Medications with social stigma
CDC Resources
Educational Materials for Professionals. From the Division for Heart Disease and Stroke Prevention.
- Fact Sheets, Data and Statistics, Maps, Reports, Guidelines and Recommendations to prevent and control cardiovascular diseases are available. Providers may share this information to patients. Available at http://www.cdc.gov/dhdsp/materials_for_professionals.htm
Million Hearts: Prevention at Work.
- Million Hearts™ is a national initiative to prevent one million heart attacks and strokes by 2017. Million Hearts™ brings together communities, health systems, nonprofit organizations, federal agencies, and private-sector partners including doctors, nurses, pharmacists, and other health care professionals, private insurers, businesses, health advocacy groups, and community organizations to support Million Hearts™ through a wide range of activities.
- Million Hearts™ aims to prevent heart disease and stroke by
Improving access to effective care
Improving the quality of care for the ABCS (Aspirin for people at risk, Blood pressure control, Cholesterol management and Smoking cessation)
Focusing clinical attention on the prevention of heart attack and stroke
Empowering the public to lead a heart-healthy lifestyle (preventing or quitting tobacco use and reducing sodium and transfat consumption)
Improving the prescription of and adherence to appropriate medications for the ABCS.
- Million Hearts™ information is available at:
http://www.cdc.gov/24-7/prevention/MillionHearts/
http://millionhearts.hhs.gov/index.html
CDC Resources – (con’t)
Team Up. Pressure Down
- Team Up. Pressure Down is a nationwide program to lower blood pressure and prevent hypertension through patient-pharmacist engagement.
- Providers may inform patients to team up with their pharmacist to better understand their condition and any medications that patients are taking.
- Through medication, healthy lifestyle changes, and working closely with their health care team, patients can get—and keep—their blood pressure under control. Available at
http://www.cdc.gov/features/tupd/
http://millionhearts.hhs.gov/resources/teamuppressuredown.html#Partners
A Program Guide for Public Health: Partnering with Pharmacists in the Prevention and Control of Chronic Diseases. From the Division for Heart Disease and Stroke Prevention and the Division of Diabetes Translation.
- This guide focuses on medication therapy management services provided by pharmacists to improve medication adherence. Available at http://www.cdc.gov/dhdsp/programs/nhdsp_program/docs/Pharmacist_Guide.pdf
Some health literacy resources are
American Medical Association Health Literacy Video
http://www.ama-assn.org/ama/pub/about-ama/ama-foundation/our-programs/public-health/health-literacy-program/health-literacy-video.page
http://www.youtube.com/watch?v=cGtTZ_vxjyA
Rhode Island Blue Cross Blue Shield developed this literacy toolkit; it is also located under the AHRQ Healthcare Innovations Exchange. Accessed on 03/14/13.
http://www.rihlp.org/pubs/Complete_toolkit_224pgs.pdf
http://www.innovations.ahrq.gov/content.aspx?id=2684
American College of Physician Foundation Health Literacy Programs and Resources on Medication Labeling
http://www.acpfoundation.org/health-literacy-programs/medication-labeling-2/
References:
Casula M, Tragni E, Catapano AL. Adherence to lipid-lowering treatment: the patient perspective. Patient Prefer Adherence 2012; 6:805-814.
Choudhry NK, Avorn J, Glynn RJ, Antman EM, Schneeweiss S, Toscano M, et al. Full coverage for preventive medications after myocardial infarction. N Engl J Med 2011;365(22), 2088-2097.
Edmondson D, Horowitz CR, Goldfinger JZ, Fei K, Kronish IM. Concerns about medications mediate the association of posttraumatic stress disorder with adherence to medication in stroke survivors. Br J Health Psychol 2013 Jan 7; doi: 10.1111/bjhp.12022. [Epub ahead of print].
Elliott RA, Barber N, Horne R. Cost-effectiveness of adherence-enhancing interventions: a quality assessment of the evidence. Ann Pharmacother 2005; 39(3):508-515.
Fongwa MN, Evangelista LS, Hays RD, Martins DS, Elashoff D, Cowan MJ, et al. Adherence treatment factors in hypertensive African American women. Vasc Health Risk Manag 2008; 4(1):157-166.
Fretheim A, Aaserud M, Oxman AD. Rational prescribing in primary care (RaPP): economic evaluation of an intervention to improve professional practice. PLoS Med 2006; 3(6):e216.
George J, Shalansky SJ. Predictors of refill non-adherence in patients with heart failure. Br J Clin Pharmacol 2007; 63(4):488-493.
References (cont.):
Gu Q, Burt VL, Dillon CF, Yoon S. Trends in antihypertensive medication use and blood pressure control among United States adults with hypertension: the National Health and Nutrition Examination Survey, 2001 to 2010. Circulation 2012; 126(17):2105-2114.
Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes. Circulation 2009; 119(23):3028-3035.
Ito K, Shrank WH, Avorn J, Patrick AR, Brennan TA, Antman, EM et al. Comparative cost-effectiveness of interventions to improve medication adherence after myocardial infarction. Health Serv Res 2012; 47(6):2097-2117.
Kronish IM, Edmondson D, Goldfinger JZ, Fei K, Horowitz CR. Posttraumatic stress disorder and adherence to medications in survivors of strokes and transient ischemic attacks. Stroke 2012; 43(8):2192-2197.
Levine DA, Morgenstern LB, Langa KM, Piette JD, Rogers MA, Karve SJ. Recent trends in cost‐related medication nonadherence among US stroke survivors. Annals of Neurology 2013 Feb 22; doi: 10.1002/ana.23823. [Epub ahead of print].
Lyles CR, Karter AJ, Young BA, Spigner C, Grembowski D, Schillinger D, et al. Patient-reported racial/ethnic healthcare provider discrimination and medication intensification in the Diabetes Study of Northern California (DISTANCE). J Gen Intern Med 2011; 26(10):1138-1144.
Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich) 2008; 10(5):348-354.
References (cont.):
Morisky DE, DiMatteo MR. Improving the measurement of self-reported medication nonadherence: response to authors. J Clin Epidemiol 2011; 64(3):255-257.
Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005; 353(5):487-497.
Rasmussen JN, Chong A, Alter DA. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA 2007;297:177–186.
Ratanawongsa N, Karter AJ, Parker MM, Lyles CR, Heisler M, Moffet HH, et al. Communication and medication refill adherence: the Diabetes Study of Northern California. Arch Intern Med 2012 Dec 31;1-9.
Steiner JF, Ho PM, Beaty BL, Dickinson LM, Hanratty R, Zeng C, et al. Sociodemographic and clinical characteristics are not clinically useful predictors of refill adherence in patients with hypertension. Circ Cardiovasc Qual Outcomes 2009; 2(5):451-457.
Viswanathan M, Golin CE, Jones CD, Ashok M, Blalock SJ, Wines RC, et al. Interventions to improve adherence to self-administered medications for chronic diseases in the United States: a systematic review. Ann Intern Med 2012; 157(11):785-795.
Walsh J, McDonald K, Shojania K, et al. Quality improvement strategies for hypertension management: a systematic review. Medical Care 2006;44:646-57.
Yeaw J, Benner JS, Walt JG, Sian S, Smith DB. Comparing adherence and persistence across 6 chronic medication classes. J Manag Care Pharm 2009; 15(9), 728-740.
Acknowledgements:
Farah M. Chowdhury, MBBS, MPH
Deesha Patel, MPH
Mary G. George, MD, MSPH, FACS
David Callahan, MD, FAAFP